This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

May 29, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making technical corrections to the April 15, 2025, final rule. These corrections are effective May 29, 2025.
Source: Federal Register
May 29, 2025 - The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Pfizer Inc., MAWD Laboratories, and Nuclein, LLC (merged with Molecular Diagnostics Inc.) related to COVID-19 detection and diagnosis tests.
Source: Federal Register
May 28, 2025 - The Centers for Medicare & Medicaid Services is seeking comments on the following information collections: 1) Application for Part B Immunosuppressive Drug Coverage (Part B-ID); 2) Data Use Agreement (DUA) Limited Data Set (LDS) Forms Research Identifiable Files (RIF) Forms; 3) Comprehensive Outpatient Rehabilitation Facility (CORF) Certification and Survey Forms; and 4) Rural Community Hospital Demonstration Program Application. Comments are due by June 27, 2025.
Source: Federal Register
May 21, 2025 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) Medicare Part C and Part D Data Validation; 2) Appointment of Representative; 3) Essential Health Benefits in Alternative Benefit Plans, Eligibility Notices, Fair Hearing and Appeal Processes, and Premiums and Cost Sharing; Exchanges: Eligibility and Enrollment; and 4) Affordable Care Act Internal Claims and Appeals and External Review Procedures for Non-grandfathered Group Health Plans and Issuers and Individual Market Issuers. Comments are due by July 21, 2025.
Source: Federal Register
May 21, 2025 - The Food and Drug Administration has revoked Emergency Use Authorizations issued to Fresenius Medical Care North America (Fresenius) multiFiltrate PRO System and multiBic/multiPlus solutions (EUA 048) and to Baxter Healthcare Corp. (Baxter) for REGIOCIT (EUA 068). These revocations are effective January 16, 2025.
Source: Federal Register
May 13, 2025 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) Medicare Geographic Classification Review Board Procedures and Criteria and 2) Part C and Part D Medicare Prescription Payment Plan Model Documents. Comments are due by July 14, 2025.
Source: Federal Register
May 12, 2025 - The Centers for Medicare & Medicaid Services is seeking comments on the following information collections: 1) Laboratory Personnel Report (CLIA) and Supporting Regulations; 2) End Stage Renal Disease (ESRD) Conditions for Coverage and Supporting Regulations; 3) Hospice Information for Medicare Part D Plans; 4) Part D Coordination of Benefits Data; and 5) Requirements Related to Surprise Billing: Qualifying Payment Amount, Notice and Consent, Disclosure on Patient Protections Against Balance Billing, and State Law Opt-in. Comments are due by June 11, 2025.
Source: Federal Register
Apr 15, 2025 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) revising the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE) regulations to implement changes related to prescription drug coverage, the Medicare Prescription Payment Plan, dual eligible special needs plans (D-SNPs), Part C and Part D Star Ratings, and other programmatic areas, including the Medicare Drug Price Negotiation Program. This final rule also codifies existing sub-regulatory guidance in the Part C and Part D programs. These regulations are effective June 3, 2025.
Source: Federal Register